Companies: 10,795·Total market cap: $144.5T
Verastem, Inc.

Verastem, Inc.

VSTMNASDAQHealthcare● Active
$3.67
$-0.04(-1.08%)
Market Cap$254382017
P/E Ratio
52W High$11.25
52W Low$3.58

Verastem, Inc. (VSTM) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · VSTM · as of 2026-06-08

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$30.91M$10.00M$0.00M$2.60M$2.05M
Cost of Revenue$5.30M$0.00M$0.00M$0.00M$0.00M
Gross Profit$25.62M$10.00M$0.00M$2.60M$2.05M
Gross Margin %(computed)82.86%100.00%100.00%100.00%
Operating Expenses
R&D Expenses$114.60M$81.33M$61.36M$50.56M$39.35M
G&A Expenses$0.00M$0.00M$0.00M$0.00M$0.00M
Total Operating Expenses$195.75M$124.96M$92.08M$75.53M$63.46M
Operating Income($170.13M)($114.96M)($92.08M)($72.94M)($61.41M)
Operating Margin %(computed)-550.33%
Interest Income$4.07M$4.15M$6.21M$1.22M$0.18M
Interest Expense$1.14M$4.56M$4.14M$2.14M$9.97M
Income Before Tax($209.47M)($130.45M)($87.37M)($73.81M)($71.20M)
Income Tax Expense$0.00M$0.18M$0.00M$0.00M$0.00M
Net Income($209.47M)($130.64M)($87.37M)($73.81M)($71.20M)
Net Margin %(computed)-677.59%
Per Share & EBITDA
EPS (Basic)$-3.02$-3.66$-3.96$-4.57$-4.92
Wtd Avg Shares69.31M35.71M22.05M16.14M14.53M
EBITDA($170.13M)($125.86M)($83.17M)($71.56M)($61.16M)
EBITDA Margin %(computed)-550.33%

Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M

Explore more Verastem, Inc. data

About Verastem, Inc. (VSTM) Income Statement

Verastem, Inc. (VSTM) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, VSTM reported revenue of $0.03B, gross profit of $0.03B (gross margin 82.86%), and net income of ($0.21B) — a net profit margin of -677.59%.

Frequently asked questions

VSTM · 4 questions

Verastem, Inc. (VSTM) reported revenue of $0.03B for 2025, up 209.1% year-over-year.

VSTM revenueVSTM salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08